Key Takeaways
- • EliseAI secures $250 million Series E funding led by Andreessen Horowitz, with new participation from Bessemer Venture Partners and continued support from Sapphire Ventures and Navitas Capital, valuing the company north of $2.2 billion.
- • Rapid headcount expansion and revenue milestone achieved: EliseAI has doubled its workforce from 150 to over 300 full-time employees since its Series D (August 2024) and surpassed $100 million in Annual Recurring Revenue (ARR) in 2025.
- • Market opportunity targets $600 billion U.S. healthcare administrative cost problem, with EliseAI focusing on automating front-desk and call center operations—two of the healthcare system's most expensive and labor-intensive pain points.
- • Dual-vertical strategy positions EliseAI in healthcare and housing markets, sectors representing approximately 40% of average American household spending, with geographic expansion planned across New York, San Francisco, Boston, and Chicago offices.
- • Aggressive hiring across engineering, customer experience, sales, and operations signals acceleration of product development and go-to-market execution to capture enterprise automation opportunities in regulated industries.
Summary
EliseAI, an AI automation company targeting healthcare and housing systems, announced a $250 million Series E funding round on August 20, 2025, led by Andreessen Horowitz with participation from Bessemer Venture Partners as a new investor alongside existing backers Sapphire Ventures and Navitas Capital. The raise values the company north of $2.2 billion, underscoring institutional confidence in its agentic AI approach to solving operational inefficiencies in mission-critical sectors.
The funding round reflects EliseAI's accelerated growth trajectory. Since closing its $75 million Series D in August 2024, the company has nearly doubled its workforce to over 300 full-time employees and achieved a significant milestone by surpassing $100 million in ARR earlier this year. Co-Founder and CEO Minna Song framed the raise as validation of EliseAI's core thesis: that agentic AI can fundamentally transform sectors where complexity and manual processes drive excessive costs. Healthcare and housing combined represent approximately 40% of household spending for the average American, creating a substantial addressable market for operational optimization.
The company is deploying capital toward aggressive team expansion across all functional areas—engineering, customer experience, sales and marketing, and strategy and operations—with concentrated office hubs in New York, San Francisco, Boston, and Chicago. This geographic footprint suggests a focus on both coastal tech talent and proximity to enterprise healthcare and housing market customers.
EliseAI's immediate focus is healthcare's most expensive administrative burden: front-desk and call center operations. U.S. healthcare administrative costs exceed $600 billion annually, driven by legacy systems, excessive manual tasks, and limited technology investment. By automating these workflows through agentic AI, EliseAI is positioned to capture significant margin improvement opportunities for hospital systems, health networks, and related service providers. The dual-vertical strategy across healthcare and housing, combined with strong revenue growth and institutional backing from tier-one venture firms, positions the company as a material player in enterprise AI automation within regulated industries.
The funding round reflects EliseAI's accelerated growth trajectory. Since closing its $75 million Series D in August 2024, the company has nearly doubled its workforce to over 300 full-time employees and achieved a significant milestone by surpassing $100 million in ARR earlier this year. Co-Founder and CEO Minna Song framed the raise as validation of EliseAI's core thesis: that agentic AI can fundamentally transform sectors where complexity and manual processes drive excessive costs. Healthcare and housing combined represent approximately 40% of household spending for the average American, creating a substantial addressable market for operational optimization.
The company is deploying capital toward aggressive team expansion across all functional areas—engineering, customer experience, sales and marketing, and strategy and operations—with concentrated office hubs in New York, San Francisco, Boston, and Chicago. This geographic footprint suggests a focus on both coastal tech talent and proximity to enterprise healthcare and housing market customers.
EliseAI's immediate focus is healthcare's most expensive administrative burden: front-desk and call center operations. U.S. healthcare administrative costs exceed $600 billion annually, driven by legacy systems, excessive manual tasks, and limited technology investment. By automating these workflows through agentic AI, EliseAI is positioned to capture significant margin improvement opportunities for hospital systems, health networks, and related service providers. The dual-vertical strategy across healthcare and housing, combined with strong revenue growth and institutional backing from tier-one venture firms, positions the company as a material player in enterprise AI automation within regulated industries.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.